Cargando…

Response Evaluation of Chemotherapy for Lung Cancer

Assessing response to therapy allows for prospective end point evaluation in clinical trials and serves as a guide to clinicians for making decisions. Recent prospective and randomized trials suggest the development of imaging techniques and introduction of new anti-cancer drugs. However, the revisi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Ki-Eun, Kim, Hak-Ryul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392484/ https://www.ncbi.nlm.nih.gov/pubmed/28416953 http://dx.doi.org/10.4046/trd.2017.80.2.136

Ejemplares similares

Elevated Prx1 Provides Resistance to Docetaxel, But Is Not Associated with Predictive Significance in Lung Cancer
por: Hwang, Ki Eun, et al.
Publicado: (2013)

Synergistic Effect of Sulindac and Simvastatin on Apoptosis in Lung Cancer A549 Cells through AKT-Dependent Downregulation of Survivin
por: Kim, Young-Suk, et al.
Publicado: (2015)

High-Resolution Time-Frequency Spectrum-Based Lung Function Test from a Smartphone Microphone
por: Thap, Tharoeun, et al.
Publicado: (2016)

Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells
por: Kim, Hyo-Jin, et al.
Publicado: (2017)

Resection of an endobronchial hamartoma by cryotherapy
por: Kim, Hak-Ryul, et al.
Publicado: (2016)

A case of pulmonary siderosis misdiagnosed as pneumonia
por: Oh, Su-Jin, et al.
Publicado: (2018)

Diagnostic Value and Prognostic Significance of Pleural C-Reactive Protein in Lung Cancer Patients with Malignant Pleural Effusions
por: Park, Do-Sim, et al.
Publicado: (2013)

Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
por: Hwang, Ki-Eun, et al.
Publicado: (2015)

Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1
por: Cha, Byong-Ki, et al.
Publicado: (2016)

Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer
por: Hwang, Ki-Eun, et al.
Publicado: (2021)

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
por: He, Yayi, et al.
Publicado: (2020)

Use of amantadine in the evaluation of response to chemotherapy in lung cancer: a pilot study
por: Maksymiuk, Andrew W, et al.
Publicado: (2021)

Case of Pseudomembranous Necrotizing Tracheobronchial Aspergillosis in an Immunocompetent Host
por: Oh, Hyo-Jeong, et al.
Publicado: (2006)

Mobile Phone App–Based Pulmonary Rehabilitation for Chemotherapy-Treated Patients With Advanced Lung Cancer: Pilot Study
por: Park, Sojung, et al.
Publicado: (2019)

Inhaled chemotherapy in lung cancer: future concept of nanomedicine
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
por: O'Byrne, Kenneth J., et al.
Publicado: (2011)

Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
por: Liu, Wei, et al.
Publicado: (2020)

Effects of Uncertainty, Appraisal of Uncertainty, and Self-Efficacy on the Quality of Life of Elderly Patients with Lung Cancer Receiving Chemotherapy: Based on Mishel’s Theory of Uncertainty
por: Hwang, Min-Kyung, et al.
Publicado: (2023)

Chemotherapy for Lung Cancer in the Era of Personalized Medicine
por: Lee, Seung Hyeun
Publicado: (2019)

Computed tomography morphologic features of pulmonary adenocarcinoma with brain/bone metastasis
por: Hwang, Ki-Eun, et al.
Publicado: (2018)

Primary Malignant Fibrous Histiocytoma of the Chest Wall Misdiagnosed as Traumatic Hemothorax
por: Hwang, Ki-Eun, et al.
Publicado: (2014)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Wang, Huan, et al.
Publicado: (2020)

New Targeted Therapy for Non-Small Cell Lung Cancer
por: Chung, Eun Ki, et al.
Publicado: (2023)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
por: Lazzari, Chiara, et al.
Publicado: (2018)

Primary Pulmonary Malignant Melanoma: An Unexpected Tumor
por: Hwang, Kyo-Bum, et al.
Publicado: (2015)

Pleural fluid characteristics of pleuropulmonary paragonimiasis masquerading as pleural tuberculosis
por: Hwang, Ki-Eun, et al.
Publicado: (2015)

Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study
por: Toffart, Anne-Claire, et al.
Publicado: (2014)

Adaptive response of resistant cancer cells to chemotherapy
por: Chern, Yi-Jye, et al.
Publicado: (2020)

Ultrasound-Responsive Nanocarriers for Breast Cancer Chemotherapy
por: Ayana, Gelan, et al.
Publicado: (2022)

Chemotherapy of lung cancer.
por: Papac, R. J.
Publicado: (1981)

Chemotherapy for small cell lung cancer: a comprehensive review
por: Karim, Syed Mustafa, et al.
Publicado: (2012)

Early Tumor–Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
por: Kim, Ryul, et al.
Publicado: (2022)

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer
por: Jeon, Hyeong-Joon, et al.
Publicado: (2011)

Adjuvant Chemotherapy of Non-Small Cell Lung Cancer
por: Pirker, Robert
Publicado: (2012)

Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy
por: Ogawara, Daiki, et al.
Publicado: (2017)

The Association of Transporter Genes Polymorphisms and Lung Cancer Chemotherapy Response
por: Wang, Ying, et al.
Publicado: (2014)

Lung Cancer in Pregnancy: An Unusual Case of Complete Response to Chemotherapy
por: Yates, Ryan, et al.
Publicado: (2015)

Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast Cancers
por: Lee, Hee Jin, et al.
Publicado: (2015)

Oral Chemotherapy for Treatment of Lung Cancer
por: Jonna, Sushma, et al.
Publicado: (2020)

Long Survival of a Small-Cell Lung Cancer Patient Who Received Maintenance Chemotherapy with Irinotecan
por: Yagi, Yoshitaka, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9eba08ur5ma6ng0uar13tjcbdn